SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 2, 2011, Pages 178-185

  Blumberga, G ^a   Groes, L ^b   Dahl, R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ALK Horsholm   (Denmark)

Author keywords

allergic asthma; bronchial hyperresponsiveness; house dust mite; immune response; immunotherapy

Indexed keywords

ALUTARD; CORTICOSTEROID; HISTAMINE; IMMUNOGLOBULIN E; METHACHOLINE; SALBUTAMOL;

ADULT; ALLERGIC ASTHMA; ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HOUSE DUST ALLERGY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; LUNG; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN ALLERGY; SKIN TEST; SPIROMETRY;

EID: 78651109811     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02451.x     Document Type: Article

References (35)

1. GINA Executive Committee. Global initiative for asthma; global strategy for asthma management and prevention. Bethesda, Maryland, USA: National Heart, Lung and Blood Institute, National Institute of Health 2009.
2. Bergeron C, Al-Ramli W, Hamid Q,. Remodeling in asthma. Proc Am Thorac Soc 2009; 6: 301-305.
3. Platts-Mills TA, Vervloet D, Thomas WR, Aalberse RC, Chapman MD,. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol 1997; 100 (6 Pt 1): S2-S24. (Pubitemid 128717763)
4. Gaffin JM, Phipatanakul W,. The role of indoor allergens in the development of asthma. Curr Opin Allergy Clin Immunol 2009; 9: 128-135.
5. Bousquet J, Lockey RF, Malling HJ,. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53: 1-42. (Pubitemid 28346358)
6. Akdis M,. Immune tolerance in allergy. Curr Opin Immunol 2009; 21: 1-8.
7. Abramson M, Puy R, Weiner J,. Immunotherapy in asthma: an updated systematic review, 2006. Allergy 2006; 54: 1022-1041.
8. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948.
9. Jacobsen L, Valovirta E,. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? Curr Opin Allergy Clin Immunol 2007; 7: 556-560.
10. Durham SR, Emminger W, Kapp A, Colombo G, De Monchy JG, Rak S, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125: 131-138.
11. Des RA, Paradis L, Knani J, Hejjaoui A, Dhivert H, Chanez P, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy 1996; 51: 430-433.
12. Blumberga G, Groes L, Haugaard L, Dahl R,. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy 2006; 61: 843-848.
13. World Medical Association. The Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects First adopted in 1964 (Helsinki, Finland) and revised in 1975 (Tokyo, Japan), 1983 (Venice, Italy), 1989 (Hong Kong), 1996 (Somerset-West, South Africa) and 2000 (Edinburgh, Scotland). Note of clarification, 2002 (Washington). 1996 Oct.
14. Nieminen MM, Lahdensuo A, Kellomaeki L, Karvonen J, Muittari A,. Methacholine bronchial challenge using a dosimeter with controlled tidal breathing. Thorax 1988; 43: 896-900.
15. Report of the working party of the European Community for Coal and Steel: "Standardization of Lung Function Tests". Bull Europ Physiopath Resp 1983; 19 (Suppl. 5): 1-95.
16. Poulsen LK, Liisberg C, Bindslev-Jensen C, Malling HJ,. Precise area determination of skin-prick tests: validation of a scanning device and software for a personal computer. Clin Exp Allergy 1993; 23: 61-68.
17. Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123: 167-173.
18. Moher D, Schulz KF, Altman DG,. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-1194. (Pubitemid 32378696)
19. O'Byrne PM, Gauvreau GM, Brannan JD,. Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009; 39: 181-192.
20. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57: 309-316.
21. Covar RA,. Bronchoprovocation testing in asthma. Immunol Allergy Clin North Am 2007; 27: 633-649.
22. Lloyd CM, Robinson DS,. Allergen-induced airway remodelling. Eur Respir J 2007; 29: 1020-1032.
23. James LK, Durham SR,. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy 2008; 38: 1074-1088.
24. Durham SR, Varney VA, Gaga M, Jacobson MR, Varga EM, Frew AJ, et al. Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy 1999; 29: 1490-1496.
25. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA,. Role of T regulatory cells in immune regulation of allergic diseases. Eur J Immunol 2010; 40: 1232-1240.
26. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92: 644-651.
27. Gould HJ, Sutton BJ,. IgE in allergy and asthma today. Nat Rev Immunol 2008; 8: 205-217.
28. Corry DB, Kheradmand F,. Induction and regulation of the IgE response. Nature 1999; 402 (6760 Suppl.): B18-B23.
29. Frew AJ,. Allergen immunotherapy. J Allergy Clin Immunol 2010; 125 (2 Suppl. 2): S306-S313.
30. Malling H-J, Lund L, Ipsen H, Poulsen LK,. Safety and immunological changes during specific sublingual immunotherapy with SQ standardized grass allergen tablets. Journal Investig Allergol Clin Immunol 2006; 16: 162-168.
31. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S,. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-809.
32. Chen ZG, Li M, Chen YF, Ji JZ, Li YT, Chen W, et al. Effects of Dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children. Chin Med J (Engl) 2009; 122: 1157-1161.
33. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl. 86): 8-160.
34. Grossman J,. One airway, one disease. Chest 1997; 111 (2 Suppl.): 11S-16S.
35. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007; 62 (Suppl. 84): 1-41.